TY - JOUR
T1 - Development of a BALB/c mice model for blue light retinal damage
AU - Wildan, Arief
AU - Rachmawati, Banundari
AU - Kartasasmita, Arief Sjamsulaksan
AU - Rahmi, Fifin Luthfia
AU - Maharani,
AU - Istiadi, Hermawan
AU - Syifarahmah, Anditta
AU - Nurdiansyah, Irwan
AU - Wulandari, Noviana Fitri
AU - Salsabilah, Shofia
N1 - Publisher Copyright:
© 2025 Journal of Advanced Pharmaceutical Technology & Research.
PY - 2025/7/1
Y1 - 2025/7/1
N2 - Blue light exposure can damage the retina, resulting in retinal atrophy and significant vision loss. Currently, no efficient animal models can observe retinal damage caused by blue light within a defined timeframe. Creating a BALB/c mouse model for blue light-induced retinal damage is expected to enhance research focused on the prevention and treatment of age-related macular degeneration. This study explores the potential effect of blue light exposure on the BALB/c mice model by analysing apoptosis and retinal degeneration. Anatomical Pathology Laboratory of Diponegoro University and The Integrated Research and Testing Laboratory of Gadjah Mada University. This study design was a posttest-only control group design. Ten five-week-old BALB/c mice were divided into two groups. The exposure group received 10,000 lux of blue light in the special cage for 2 weeks, 3 h daily. Caspase-3 expression was assessed through polymerase chain reaction testing, and retinal thickness was analyzed using hematoxylin and eosin staining. We used the Shapiro-Wilk test to evaluate data normality. Parametric t-tests and nonparametric Mann-Whitney tests were applied to compare groups, with P < 0.05 considered significant. The average whole retinal thickness of the exposed group was 152.812 ± 20.919 μm, while the control group was 214.948 ± 53.284 μm (P = 0.04). The average caspase-3 expression in the exposed group was 19.03 ± 8.57 μm, while the control group was 5.78 ± 2.63 μm (P = 0.011). This approach, utilizing animal models for blue light exposure, can be employed to learn about retinal damage caused by blue light.
AB - Blue light exposure can damage the retina, resulting in retinal atrophy and significant vision loss. Currently, no efficient animal models can observe retinal damage caused by blue light within a defined timeframe. Creating a BALB/c mouse model for blue light-induced retinal damage is expected to enhance research focused on the prevention and treatment of age-related macular degeneration. This study explores the potential effect of blue light exposure on the BALB/c mice model by analysing apoptosis and retinal degeneration. Anatomical Pathology Laboratory of Diponegoro University and The Integrated Research and Testing Laboratory of Gadjah Mada University. This study design was a posttest-only control group design. Ten five-week-old BALB/c mice were divided into two groups. The exposure group received 10,000 lux of blue light in the special cage for 2 weeks, 3 h daily. Caspase-3 expression was assessed through polymerase chain reaction testing, and retinal thickness was analyzed using hematoxylin and eosin staining. We used the Shapiro-Wilk test to evaluate data normality. Parametric t-tests and nonparametric Mann-Whitney tests were applied to compare groups, with P < 0.05 considered significant. The average whole retinal thickness of the exposed group was 152.812 ± 20.919 μm, while the control group was 214.948 ± 53.284 μm (P = 0.04). The average caspase-3 expression in the exposed group was 19.03 ± 8.57 μm, while the control group was 5.78 ± 2.63 μm (P = 0.011). This approach, utilizing animal models for blue light exposure, can be employed to learn about retinal damage caused by blue light.
KW - Age-related macular degeneration
KW - BALB/c mice
KW - blue light-induced
KW - retinal thickness
UR - https://www.scopus.com/pages/publications/105012841899
U2 - 10.4103/JAPTR.JAPTR_32_25
DO - 10.4103/JAPTR.JAPTR_32_25
M3 - Article
AN - SCOPUS:105012841899
SN - 2231-4040
VL - 16
SP - 139
EP - 143
JO - Journal of Advanced Pharmaceutical Technology and Research
JF - Journal of Advanced Pharmaceutical Technology and Research
IS - 3
ER -